DB16086Investigational
Aldafermin is under investigation in clinical trial NCT03912532 (Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study in Subjects With Nonalcoholic Steatohepatitis...
- Mechanism
- Curator reviewed
Pharmacologically active on Fibroblast growth factor 19
- Also known as
- (phe5>met,ser6>arg,ala8>ser,gly9>ser,his11>leu) fibroblast growth factor 19 (human fgf19) (5-194)-peptide, produced in escherichia coli · Engineered variant of recombinant human fibroblast growth factor 19
- Code names
- NGM-282
Resolves to
Compound
Targets
What you can answer from here — as of September 14, 2026
Which drugs share a target with Aldafermin, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account